Back to News
Market Impact: 0.15
Sales of Leqembi® totaled 32.2 billion yen in the third quarter 2026
Source: PR Newswire
Healthcare & BiotechCorporate EarningsCompany Fundamentals
Eisai published preliminary global third-quarter 2026 Leqembi sales alongside Biogen’s third-quarter report. The excerpt gives the amount only as “JPY 32.2...” and does not provide a complete figure or comparison.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- What investors need to know about Alphabet's stock-busting earnings report
- Our next steps for Alphabet stock after earnings disappoint at nearly every turn
- Wendy's shares jump 15% as Nelson Peltz's Trian offers $1.4 billion to buy burger chain
- GE Vernova shares slip despite a beat-and-raise. What the sellers are getting wrong
- Microsoft's Big Bets on AI Start to Pay Off
- Asian shares fall as Alphabet earnings miss drags Wall St futures lower